Libra Infusions Limited (DSE: LIBRAINFU)
Health Care · Pharmaceuticals · BD
Tk551.00
-2.53% today · -25.9% 1Y
Libra Infusions Limited (DSE: LIBRAINFU) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.08M.
Over the last twelve months the share price has lost 25.9%, trading between 547.10 and 779.00.
Tweenvest scores Libra Infusions Limited across four factors: quality 52/100, value 45/100, growth 0/100. Its strongest factor is quality.
LIBRAINFU price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.08M
- Revenue (TTM)
- $2.33M
- P/E
- —
- EPS
- 0.70
- Dividend yield
- —
- Beta (5Y)
- -0.22
- 52-week high
- Tk779.00
- 52-week low
- Tk547.10
- Avg volume (3M)
- —
- Shares outstanding
- 2.25M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Purple Biotech LtdTASE: PPBT | $10.54M | ₪0.01 | 0.00% |
| Sotac Pharmaceuticals LimitedNSEI: SOTAC | $10.33M | Rs90.05 | — |
| Veerhealth Care LimitedBSE: 511523 | $10.24M | Rs49.57 | -0.62% |
| Adial Pharmaceuticals, Inc.NasdaqCM: ADIL | $10.24M | $3.56 | -8.72% |
| Advent Pharma Ltd.DSE: ADVENT | $9.91M | Tk13.10 | -2.24% |
| Y.B Urban Renewal - Residential Development LtdTASE: YBRD | $9.70M | ₪6.15 | +8.43% |
| Rapid Dose Therapeutics Corp.CNSX: DOSE | $9.66M | CA$0.10 | -16.67% |
| Concord Drugs LimitedBSE: 538965 | $9.58M | Rs70.40 | -7.00% |
Figures last refreshed Oct 11, 2026.